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Direct detection of circulating nutrients by the central
nervous system has been implicated in the regulation
of energy balance, and the mediobasal hypothal-
amus is considered as the primary sensing site medi-
ating these effects. Neurons sensitive to energy-
related signals have also been identified outside the
hypothalamus, particularly within the caudomedial
nucleus of the solitary tract (cmNTS) in brainstem,
but the consequences of direct cmNTS nutrient
detection on energy balance remain poorly charac-
terized. Here we determined the behavioral and
metabolic consequences of direct L-leucine detec-
tion by the cmNTS and investigated the intracellular
signaling and neurochemical pathways implicated
in cmNTS L-leucine sensing in rats. Our results sup-
port the distributed nature of central nutrient detec-
tion, evidence a role for the cmNTS S6K1 pathway
in the regulation of meal size and body weight, and
suggest that the cmNTS integrates direct cmNTS
nutrient detectionwith gut-derived, descending fore-
brain, and adiposity signals of energy availability to
regulate food intake.
INTRODUCTION
Within the central nervous system (CNS), specialized metabolic-
sensing neurons modify their electrical and synaptic activity in
response to signals related to body’s fuel status (Levin, 2006).
Metabolic-sensing neurons are believed to play a critical role in
the regulation of energy balance as a unique site of anatomical
convergence of multiple signals of both acute and chronic
energy availability, coupling detection and integration of these
signals to coordinate effector functions that determine energy
intake and utilization (Woods, 2009). However, the mechanisms
underlying the integration of multiple fuel-related signals within
the CNS, as well as the neuroanatomical distribution and organi-
zation of CNS metabolic-sensing circuits remain poorly
characterized.
Metabolic-sensing neurons have been mainly localized in
selective nuclei of the hypothalamus, particularly within the
mediobasal hypothalamus (ventromedial and arcuate nuclei of
the hypothalamus), historically considered as the cornerstone
of CNS fuel detection (Jordan et al., 2010; Levin et al., 2011;
Woods, 2009). Mediobasal hypothalamic neurons have beenCell Mshown to detect adiposity and gut-derived signals of energy
availability (Ko¨nner et al., 2009; Nogueiras et al., 2008), as well
as representatives of all three classes of macronutrients
(glucose, fatty acids, and amino acids) (Blouet et al., 2009;
Ibrahim et al., 2003; Jo et al., 2009; Obici et al., 2002; Wang
et al., 2004). In response to these various signals, mediobasal
hypothalamic metabolic-sensing neurons engage a complex
set of neurochemical and neurophysiological responses to
produce integrated commands to hindbrain neurons regulating
behavioral and metabolic determinants of energy homeostasis.
Neurons sensitive to energy-related signals have also been
identified outside the hypothalamus, challenging this hypothala-
mocentric view of CNS fuel sensing. Evidence supporting the
physiological relevance of a more distributed nature of CNS
fuel sensing (Grill, 2006) include the feeding and motivational
responses to leptin, GLP-1 and ghrelin detection in the midbrain
ventral tegmental area (Dickson et al., 2012; Hommel et al., 2006;
Skibicka et al., 2011), or the feeding consequences of leptin,
GLP-1, and ghrelin signaling in the nucleus of the solitary tract
in the hindbrain (NTS) (Faulconbridge et al., 2003; Grill et al.,
2002; Hayes et al., 2009, 2010; Huo et al., 2007). The hypotha-
lamic framework of CNS fuel sensing is further challenged by
data supporting a role for the NTS as an important center of
convergence and integration of multiple signals of energy avail-
ability. Initially described as a primary site receiving postinges-
tive afferent information from the gastrointestinal tract important
in the negative feedback control of meal size (Schwartz et al.,
2000), the NTS has recently been shown to integrate forebrain
descending melanocortinergic input and leptin signals with
gut-derived satiety signals to determine food intake (Blevins
et al., 2004, 2009; Sutton et al., 2004, 2005; Zhao et al., 2012).
Surprisingly, the functional consequences of direct nutrient
detection by NTS neurons in the regulation of energy balance
have received little attention, apart from work demonstrating
the role of NTS glucose sensing in the feeding and glucoregula-
tory response to hypoglycemia (Ritter et al., 2000; Sanders et al.,
2004) Furthermore, the potential NTS integration of direct NTS
nutrient sensing with other signals of energy availability remain
unexplored.
We previously found that L-leucine sensing by the mediobasal
hypothalamus regulates energy balance and implicated the acti-
vation of the amino acid-sensing p70 S6 kinase 1 (S6K1)
signaling pathway in L-leucine detection (Blouet et al., 2008,
2009). In the current work, in part based on its previously deter-
mined nutrient-sensing capabilities and its proximity to the cir-
cumventricular area postrema (AP), a region of specialized
access to circulatory factors at the blood brain barrier interface,
we hypothesized that the NTS may be implicated in CNS aminoetabolism 16, 579–587, November 7, 2012 ª2012 Elsevier Inc. 579
Figure 1. NTS L-Leucine Administration Reduces Food Intake and
Body Weight
Food intake (A), 24 hr body weight change (B), first meal size (C), mean meal
size (D), and cumulative meal number (E) in rats after a bilateral injection of
aCSF or L-leucine into the cmNTS. Data are means ± SEM (n = 12). *p < 0.05,
**p < 0.01. See also Figure S1.
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nutrient-sensing capabilities of the rat NTS by examining
the feeding andmetabolic effects of direct NTS L-leucine admin-
istration. We characterized the neurochemical identities of
NTS L-leucine sensing neurons, investigated the intracellular
signaling mechanisms underlying NTS L-leucine sensing, and
directly tested the role of the NTS S6K1 pathway in the control
of energy homeostasis. Last, we employed signaling, behavioral,
and physiological measurements to examine whether NTS
neurons could integrate L-leucine stimulation with other signals
of energy availability to determine food intake and body weight.
RESULTS
NTS L-Leucine Administration Reduces Food Intake
and Body Weight
To identify whether the caudomedial NTS (cmNTS) senses the
local availability of amino acids in ways relevant for energy
balance, we examined the behavioral and metabolic conse-
quences of direct L-leucine administration into the cmNTS
(spanning the rostrocaudal extent of the area postrema) in terms
of food intake and body weight. We used a dose of L-leucine
2-fold lower than the dose previously used in MBH parenchymal
injection studies, which was in the physiological range of the
postprandial cerebrospinal L-leucine increase (Blouet et al.,
2009). Bilateral NTS L-leucine administration (25 ng in 100 nl
aCSF, per side) to 24 hr fasted rats significantly reduced 24 hr
food intake (Figure 1A) and decreased 24 hr body weight change
(Figure 1B) compared with aCSF vehicle injections. Meal pattern
analyses revealed that NTS L-leucine administration rapidly
produced a 40% decrease in the first meal size within the first
20 min after the injection (Figure 1C), and reduced meal size
was maintained throughout the 24 hr after the injection (Fig-
ure 1D). NTS L-leucine also decreased meal number beginning
6 hr after the injection (Figure 1E).580 Cell Metabolism 16, 579–587, November 7, 2012 ª2012 ElsevierTo assess the specificity of the DVC L-leucine response
with respect to other branched-chain amino acids, we examined
the feeding-inhibitory effect of an equimolar dose of the
branched-chain amino acid valine. NTS Valine administration
failed to alter food intake and body weight change compared
with aCSF control injections (Figure S1 available online).
NTS L-Leucine Sensing Regulates Food Intake and Body
Weight through the Activation of the S6K1 Pathway
Unlike valine, L-leucine is a strong activator of the mTORC1/p70
S6 kinase 1 signaling pathway (Proud, 2004). Therefore, we
hypothesized that L-leucine administration into the NTS acti-
vates the amino acid-sensing mTORC1/p70 S6 kinase 1
signaling pathway and that activation of this pathway is impli-
cated in NTS L-leucine sensing and its effects on food intake
and body weight. Consistent with this hypothesis, NTS adminis-
tration of L-leucine at a dose that suppressed feeding signifi-
cantly increased the expression of the activated phosphorylated
form of p70 S6 kinase 1 (pS6K1, phosphorylated a threonine 789)
in the dorsal vagal complex (DVC; which includes the NTS, the
dorsal motor nucleus of the vagus [DMV] and the AP) within
30 min of injection (Figure 2A). NTS administration of L-leucine
also increased the number of ribosomal protein S6 (pS6, phos-
phorylated at Ser240 and Ser244, a downstream effector of
S6K1) immunoreactive neurons in the NTS (Figure 2B),
compared to NTS aCSF administration. In contrast, NTS
L-leucine administration did not alter the activity of the AMP-
activated protein kinase (AMPK) in the DVC, as assessed by
a2-AMPK threonine 172 phosphorylation (data not shown).
We next characterized the neurochemical phenotype of NTS
neurons that exhibit L-leucine-induced pS6 expression using
immunofluorescence. Our attention was focused on the cate-
cholaminergic neurons located in the NTS because they have
been strongly implicated in the regulation of meal size (Rinaman,
2011; Zhang et al., 2010) and on NTS POMC neurons because
we previously found that L-leucine directly depolarizes POMC
neurons in the arcuate nucleus of the hypothalamus (Blouet
et al., 2009) and because NTS POMC neurons have been shown
to contribute to the regulation of meal size (Babic et al., 2009;
Fan et al., 2004). We found that NTS L-leucine administration
induces pS6 expression in 36% ± 3.61% of neurons expressing
dopamine b hydroxylase (Figure 2C), 45% ± 2.78% of neurons
expressing tyrosine hydroxylase (Figure 2D), and 52% ± 7.3%
of neurons expressing POMC (Figure 2E).
To test whether activation of NTS POMC neurons may be
involved in NTS leucine-induced anorexia, we assessed the
effect of the melanocortin analog SHU9119, a MC3/4R antago-
nist. Coadministration of NTS leucine with a subthreshold dose
of SHU9119 i.c.v. blocked NTS leucine-induced decreases in
food intake, first meal size, and meal size (Figure 2F), indicating
that NTS leucine’s effects on food intake require activation of
MC3/4R.
To determine whether the stimulation of NTS S6K1 signaling
is required for L-leucine-induced reduction of food intake,
we combined NTS administration of the well-characterized
mTORC1 inhibitor rapamycin, at a dose that did not affect
food intake, with an NTS injection of L-leucine. Rapamycin
completely blocked L-leucine-induced decreases in food intake,
body weight, first meal size, and meal size but did not affectInc.
Figure 2. NTS L-Leucine Activates NTS S6K1 Signaling and This
Activation Is Required for NTS L-Leucine’s Anorexigenic Effects
(A and B) NTS S6K1 Thr389 phosphorylation (n = 5) (A) and NTS pS6 immu-
noreactivity (n = 4) (B) in 24 hr-fasted rats 30 min after a bilateral NTS aCSF or
L-leucine injection.
(C–E) Colocalization (right, orange) of DBH (C), TH (D), or POMC (E) (left, red)
with pS6 (middle, green) in 24 hr-fasted rats 30 min after a bilateral NTS L-
leucine injection (n = 4).
(F) Food intake, first meal size, and meal size after an i.c.v. injection of aCSF or
SHU9119combinedwithabilateral injectionofaCSForL-leucine into thecmNTS.
(G) Food intake, 24 hr body weight change, first meal size, meanmeal size, and
cumulative meal number in rats after a bilateral injection of aCSF or L-leucine
combined to a bilateral injection of DMSO or rapamycin into the cmNTS.
Figure 3. Acute Inhibition of NTS S6K1 Signaling Increases Food
Intake
(A and B) DVC pS6 immunoreactivity in 24 hr-fasted (A) and 30 min-refed
(B) rats.
(C–G) First meal latency (C), first meal size (D), food intake (E), mean meal size
(F), and cumulative meal number (G) in rats after a bilateral injection of DMSO
or rapamycin into the cmNTS.
Data are means ± SEM (n = 12). *p < 0.05. See also Figure S4.
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Cell ML-leucine-induced decreases in meal number (Figure 2G). These
data suggest that activation of theNTSmTORC1/p70S6 kinase 1
pathway after NTS L-leucine treatment induces both an acute
and a sustained decrease in food intake that is mediated by
adecrease inmeal size, anda reduction in 24hrbodyweight gain.
NTS S6K1 Mediates the Control of Energy Balance
Rapamycin’s ability to block NTS L-leucine-induced reductions
in meal size indicate that the mTORC1/S6K1 pathway is an
important effector of NTS L-leucine signaling in the regulation
of energy balance. Accordingly, we asked whether NTS S6K1
activity is also sensitive to nutritional whole-body energy status.
Previous findings indicate that fasting and refeeding modify the
expression of pS6K1 and pS6 exclusively in the arcuate nucleus
of the hypothalamus in the rat forebrain, with no change in the
activation of extra-arcuate hypothalamic sites, hippocampus
or cortex (Cota et al., 2006). Using immunofluorescence, we
found that the NTS is also a CNS site where the S6K1 signaling
pathway is activated upon refeeding. Expression of pS6 was
absent in the cmNTS of overnight fasted rats (Figure 3A) and
was robustly induced during refeeding (Figure 3B).
To directly assess the role of endogenous NTS S6K1 signaling
in the regulation of energy balance, we next investigated theData are means ± SEM (n = 12). *p < 0.05. Scale bars represent 100 mm. See
also Figures S2–S4.
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Figure 4. NTS S6K1 Is a Physiologically Relevant Nutrient Sensor
Regulating the Control of Energy Balance
(A) NTS S6K1 Thr389 phosphorylation in fasted rats bilaterally infected with the
LACZ or CA S6K adenovirus in the NTS.
(B–E) Food intake (B), mean meal size (C), cumulative meal number (D), and
body weight (E) in rats bilaterally infected with the LACZ or CA S6K adenovi-
ruses in the NTS (n = 6).
(F and G) Fat mass (F) and fat-free mass (G) in rats 10 days after NTS bilateral
infection with the LACZ or CA S6K adenovirus.
Data are means ± SEM (n = 6). *p < 0.05.
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rapamycin (2.5 mg in 100 nl DMSO, per side) to presated rats
(which were overnight fasted and refed for 1 hr) dramatically
decreased first meal latency (Figure 3C) and increased first
meal size (Figure 3D) compared with DMSO vehicle injections.
NTS rapamycin-induced hyperphagia was sustained through
the 24 hr after the injection (Figure 3E) andwas completely attrib-
utable to an increase in meal size (Figure 3F) with no change in
meal number (Figure 3G).
We then bilaterally targeted the NTS with recombinant adeno-
viruses expressing a constitutively active mutant of S6K1 (CA
S6K) or LACZ (control). We previously confirmed the functional
validity of the CA S6K in GT1–7 hypothalamic cell lines (Blouet
et al., 2008), and here we confirmed that expression of the con-
stitutively active mutant of S6K1 induced a significant increase
in DVC S6K1 protein expression (Figure 4A, S6K1/actin expres-
sion: 1.39 ± 0.06 versus 2.37 ± 0.18 in LACZ versus CA S6K1
infected NTS). Overactivation of S6K1 in the NTS induced a
sustained reduction in food intake beginning on the first day after
the viral injection and persisting for the following week (Fig-
ure 4B). This reduction in food intake was due to a reduction in
meal size (Figure 4C), with no change inmeal number (Figure 4D).
Anorexia in S6K1-overexpressing rats lead to a modest but
significant reduction in body weight gain starting 4 days after
the NTS viral injection (Figure 4E) and a 25% reduction in fat582 Cell Metabolism 16, 579–587, November 7, 2012 ª2012 Elseviermass (Figure 4F). Taken together, these data support an impor-
tant role for NTS S6K signaling in the control of food intake and
energy balance.
Integration of NTS L-Leucine Sensing with Acute and
Chronic Signals of Energy Availability in the Control of
Meal Size
NTS neurons have been shown to process gut-derived neural
and humoral satiation signals after ingestion of food (Grill and
Hayes, 2009; Hayes et al., 2009; Moran, 2006), adiposity signals
conveying information about long-term energy storage such as
leptin (Grill et al., 2002; Hayes et al., 2010), and descending
forebrain melanocortinergic signals (Wan et al., 2008), and
accumulating evidence indicates that NTS neurons integrate
these signals to determine meal size. Thus, we asked whether
nutrient signals such as L-leucine also interacted with these
various signals of acute and chronic energy availability.
We first investigated the interaction between L-leucine and the
well-characterized gut-derived satiety signal cholecystokinin
(CCK). We found that a subthreshold dose of i.p. CCK (0.5 mg/
kg BW) enhanced the acute anorexigenic effect of NTS L-leucine
(25 ng in 100 nl aCSF, per side), suggesting that CCK and
L-leucine signals interact in the NTS to acutely limit food intake
by limiting meal size (Figure 5A). Likewise, a subthreshold dose
of NTS leptin (3 ng in 100 nl/side) enhanced the acute anorexi-
genic effect of NTS L-leucine (Figure 5B). Last, a subthreshold
dose of NTS melanotan II (2 pmol in 100 nl per side) enhanced
the acute anorexigenic effect of NTS L-leucine (Figure 5C).
Together, these data indicate that NTS L-leucine sensing is inte-
grated within the NTS with gut-derived, forebrain-descending,
and adiposity signals of energy availability to control meal size.
NTS L-Leucine Sensing Activates the NTS ERK1/2
Signaling Pathway
NTS Erk1/2 signaling has been implicated in the regulation of
meal size and proposed as a molecular integrator of various
signals of energy availability in the NTS (Sutton et al., 2005; Sut-
ton et al., 2004). Thus, we tested whether NTS L-leucine admin-
istration activates the Erk1/2 signaling pathway in the NTS. NTS
administration of an anorexigenic dose of L-leucine rapidly and
significantly increased the expression of the activated phosphor-
ylated form of ERK1/2 (pERK1/2, phosphorylated at Threonine
202/Tyrosine204) in the DVC within 30 min (Figure 6A).
To test whether activation of NTS ERK1/2 signaling pathway is
required for NTS L-leucine anorexigenic effect, we coadminis-
tered NTS L-leucine with a subthreshold dose of NTS U0126
(25 ng in 100 nl per side in DMSO:saline 50:50), a specific
Erk1/2 inhibitor. Subthreshold NTS U0126 blocked the effect of
NTS L-leucine on food intake, body weight gain, first meal size,
and meal size (Figures 6B–6E).
Last, we asked whether the ERK1/2 signaling pathway acts as
a molecular integrator of L-leucine signals and gut-derived
signals of acute energy availability. We coadministered an NTS
anorexigenic dose of L-leucine with a subthreshold dose of i.p.
CCK and assessed the activity of the DVC ERK1/2 signaling
pathway. Intraperitoneal CCK and NTS L-leucine had an additive
effect on DVC ERK1/2 phosphorylation (Figure 6F). In contrast,
i.p. CCK,which did notmodify S6K1 activity alone, did not further
increase L-leucine-induced S6K1 activation (data not shown).Inc.
Figure 5. The NTS Integrates i.p. CCK, NTS Leptin and NTS MTII Signals with L-Leucine Sensing to Acutely Decrease Meal Size
First meal size after NTS bilateral administration of an anorexigenic dose of L-leucine combined with a subthreshold dose of i.p. CCK (A), a subthreshold dose of
NTS leptin (B), or a subthreshold dose of NTS MTII (C). Data are means ± SEM (n = 12). Means sharing a common letter are not significantly different (p > 0.05).
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Mediobasal hypothalamic nutrient detection has been impor-
tantly implicated in the regulation of energy balance, but little is
known about extrahypothalamic nutrient-sensing sites and their
contribution to the negative feedback control of food intake and
body weight. Here we show that direct L-leucine detection by
the cmNTS regulates food intake and body weight gain through
the activation of the S6K1 signaling pathway, and we identify
NTS catecholaminergic and POMC neurons as L-leucine-
sensing cells. We show that bidirectional modulation of NTS
S6K1 activity is sufficient to produce reciprocal alterations in
food intake through specific changes in meal size, with sig-
nificant consequences for body weight gain. We found that
NTS L-leucine administration also activates the Erk1/2 signaling
pathway in the NTS, and this activation is required for
NTS L-leucine’s effects on food intake and body weight.
Coadministration of subthreshold doses of i.p. CCK, NTS leptin,
or NTS melanotan II with NTS L-leucine all increase the acute
anorexigenic effects of NTS L-leucine. Last, subthreshold i.p.
CCK and NTS L-leucine have additive effects on NTS Erk1/2 acti-
vation. Together, our results (1) support the distributed nature of
central nutrient detection, (2) evidence a role for the NTS S6K1
pathway in the regulation of meal size and body weight, and (3)
suggest that NTS Erk1/2 signaling integrates direct NTS nutrient
detection with forebrain-descending, gut-derived, and adiposity
signals of energy availability to regulate food intake.
This work demonstrates that extrahypothalamic nutrient
detection contributes to the negative feedback control of energy
balance. NTS glucose sensing has been previously implicated in
the glucoprivic feeding and homeostatic control of blood
glucose (Balfour and Trapp, 2007; Ritter et al., 2000; Sanders
et al., 2004), but the potential anorectic response to increased
NTS glucose levels remains unexplored. Together with the
recent findings establishing the role of direct NTS leptin, GLP-
1, and ghrelin sensing in the homeostatic regulation of food
intake (Faulconbridge et al., 2003; Grill et al., 2002; Hayes
et al., 2009; Hayes et al., 2010), these data support a role for
the cmNTS as an important metabolic-sensing niche in the
regulation of energy balance and a site of neuroanatomical
convergence of all types of acute and chronic signals of energy
availability.
Our data suggest that several mechanisms are engaged by
NTS L-leucine to decrease food intake. First, both NTS L-leucine
treatment and constitutive activation of NTS S6K1 activity
reduce meal size. Such a behavioral response has been typicallyCell Massociated with the intake suppressive effects of GI-derived
satiation signals such as CCK or gastric distention (Moran,
2006). Consequently, L-leucine detection could modulate
presynaptic transmission from vagal terminals to NTS neurons
or increase the sensitivity of NTS neurons to gut-derived gluta-
matergic inputs. These two mechanisms have been proposed
to be implicated in the feeding-modulatory effect of hindbrain
melanotan II, hindbrain leptin, and hindbrain ghrelin (Cui et al.,
2011; Emond et al., 1999; Huo et al., 2007; Schwartz and Moran,
2002; Sutton et al., 2005). Consistent with this, we found that i.p.
CCK and NTS L-leucine synergistically decrease meal size and
activate the NTS Erk1/2 pathway. In addition, NTS L-leucine
administration increases pS6 immunoreactivity in NTS POMC
neurons that modulate glutamatergic presynaptic activity of
vagal terminals (Wan et al., 2008), and in NTS catecholaminergic
neurons, required for CCK’s anorexigenic effects (Rinaman,
2003; Rinaman et al., 1993). In fact, NMDAR and AMPA/KA
signaling activate S6K1 phosphorylation in cultured glial and
neuronal cells (Gonza´lez-Mejia et al., 2006; Lenz and Avruch,
2005), and this activation is implicated in long-term potentiation,
supporting a potential role for S6K1 signaling in increasing sensi-
tivity to depolarizing inputs. However, activation of feeding-regu-
latory mechanisms independent of gut-derived signals cannot
be ruled out. For example, we found that NTS L-leucine
decreases meal frequency, a behavioral response that is not
characteristically triggered by peripheral detection of meal-
related gut-derived signals (Smith, 1996). Anorexia mediated
by a decrease in meal number has also been reported after hind-
brain GLP1-receptor activation (Hayes et al., 2011), supporting
the idea that NTS feeding-modulatory actions are not restricted
to the regulation of meal size but rather encompass multiple
behavioral determinants of food intake.
Another important aspect of our work is the demonstration of
a role for NTS S6K1, an evolutionarily conserved nutrient-
sensing enzyme, as a physiologically relevant nutrient sensor
contributing to the NTS mechanisms regulating energy balance.
We found that (1) NTS S6K1 bidirectionally regulates food intake
through a specific effect on meal size and (2) NTS S6K1 activity
is modulated by signals of energy availability (L-leucine and
refeeding). Importantly, we found that acute inhibition of NTS
mTOR/S6K1 signaling rapidly increases food intake in sated
rats, with a 5-fold decrease in the first meal latency and a
2-fold increase in the first meal size after NTS rapamycin admin-
istration, supporting a role for endogenous NTS S6K1 tone in
both meal initiation and meal termination. This latter effect is
sustained during the 24 hr of the test, suggesting that NTSetabolism 16, 579–587, November 7, 2012 ª2012 Elsevier Inc. 583
Figure 6. Activation of NTS Erk1/2 Signaling Is Required for NTS
L-Leucine Anorexigenic Effect, and NTS Erk1/2 Acts as a Molecular
Integrator of i.p. CCK and NTS L-Leucine
(A) DVC Erk1/2 Thr202/Tyr204 phosphorylation in 24 hr-fasted rats 30 min after
an NTS administration of aCSF or L-leucine (n = 5).
(B–E) Food intake (B), 24 hr body weight change (C), first meal size (D), and
mean meal size (E) in rats after a bilateral injection of aCSF or L-leucine
combined to a bilateral injection of DMSO:saline (1:1) or U0126 into the cmNTS
(n = 12).
(F) DVC Erk1/2 Thr202/Tyr204 phosphorylation in 24 hr-fasted rats 30 min after
an NTS administration of aCSF or L-leucine combined with an i.p. injection of
saline or CCK.
Data are means ± SEM (n = 5). *p < 0.05.
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nants of meal size. Previously shown to be an important MBH
nutrient sensor modulating the regulation of energy balance
(Blouet et al., 2008), these results broaden the neuroanatomical
basis for the contribution of the S6K1 pathway in central nutrient
sensing and the regulation of energy homeostasis. In contrast to
NTS leucine, bidirectional manipulations of NTS mTORC1
pathway do not affect meal frequency, indicating that mecha-
nisms independent from the activation of mTORC1 regulate
meal size after leucine detection. These could include leucine
catabolism to AcetylCoA, as has been previously shown in the
mediobasal hypothalamus (Blouet et al., 2009). Interestingly,
although NTS and MBH upregulation of S6K1 both led to a sus-
tained reduction in food intake that is mediated by a reduction in
meal size, these two manipulations did not produce similar
consequences on body weight and body composition. MBH584 Cell Metabolism 16, 579–587, November 7, 2012 ª2012 ElsevierS6K1 upregulation produced sustained reductions in body
weight gain, whereas overactivation ofNTSS6K1 led to amodest
and transient decrease in body weight. In contrast, MBH S6K1
upregulation did not affect body composition, whereas upregu-
lation of S6K1 in the NTS decreased fat mass and increased fat
free mass, these two effects compensating and minimizing
overall body weight changes. Together, these results support
the conclusion that MBH and NTS nutrient sensing are both
redundant and complementary.
The finding that the NTS integrates L-leucine sensing with the
detection of gut-derived, adiposity, and descending forebrain
signals to regulatemeal size extends previous evidence support-
ing NTS integrative capacity to include nutrient signals. Con-
sistent with findings supporting a role for Erk1/2 signaling as
a point of molecular convergence and integration of CCK, leptin,
and melanocortinergic signals in NTS neurons to reduce meal
size (Campos et al., 2012; Hayes et al., 2011; Sutton et al.,
2005; Sutton et al., 2004), we found that NTS L-leucine detection
also converges on the Erk1/2 signaling pathway. The mecha-
nisms underlying L-leucine-induced Erk1/2 activation remain to
be established and could implicate both an intracellular molec-
ular interaction between Erk1/2 and S6K1 signaling and an
indirect activation of Erk1/2 in the NTS through modulations of
melanocortinergic and glutamatergic tone after NTS L-leucine
sensing, both of which have been shown to be coupled to
Erk1/2 activation (Campos et al., 2012; Daniels et al., 2003).
mTOR and AMPK are both nutrient sensors importantly impli-
cated in CNS fuel sensing and the regulation of energy balance
(Hardie et al., 2012; Woods et al., 2008), but the crosstalk
between these two pathways remains only partially character-
ized. While the current understanding is that AMPK is an
upstream regulator of mTOR through TSC2 (Inoki et al., 2003), in-
tracerebroventricular leucine was found to decrease hypotha-
lamic a2-AMPK threonine 172 phosphorylation, suggesting
that leucine-induced mTOR activation inhibits AMPK activity
(Ropelle et al., 2008). Here, we found that NTS L-leucine
administration did not modify a2-AMPK threonine 172 phos-
phorylation, consistent with the finding that constitutive activa-
tion of S6K1 in hypothalamic GT1-7 neurons does not affect
a2-AMPK threonine 172 phosphorylation (Dagon et al., 2012).
Recently, S6K1 has been described as a negative regulator of
AMPK activity through novel phosphorylation sites (Dagon
et al., 2012), but the recruitment of these sites after leucine-
induced S6K1 activation remains to be tested.
The ability of i.c.v. SHU9119 to block both the acute and
longer-term anorexia induced by cmNTS leucine demonstrates
a critical role for NTS leucine-induced activation of NTS POMC
neurons in these feeding effects. Whether NTS POMC neurons
engage melanocortin receptors specifically within the NTS to
suppress feeding remains to be determined.
Our results build on a growing challenge to a hypothalamic-
centered view of central nutrient sensing and support a role for
the NTS as a place of convergence and integration of multiple
fuel-related signals important to the regulation of food intake.
Our data also broaden the behavioral and metabolic contribu-
tions of NTS fuel sensing to include the regulation of meal
frequency, fat mass, and fat-free mass. It remains to be estab-
lished whether the anorectic effects of NTS L-leucine require
hindbrain ascending projections to the forebrain and/or localInc.
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will be critical to understanding the behavioral and physiological
relationships among forebrain and hindbrain nutrient-sensing
capabilities.
EXPERIMENTAL PROCEDURES
Animals and Reagents
Sprague Dawley rats (275–300 g, Charles River Laboratories) were housed in
individual cages and maintained in a temperature-controlled room under
a standard 12 hr/12 hr light/dark cycle with ad libitum access to water and
standard chow, unless specifically indicated. Before any behavioral, signaling,
and immunostaining studies, animals were trained daily to be attached to the
brain injection system for at least the four consecutive days preceding the
injection. All experimental protocols were approved by the Institute for Animal
Studies of the Albert Einstein College of Medicine.
CNS Chronic Cannula Implantation
Surgical procedures were performed under ketamine/xylazine anesthesia. For
third ventricle cannula implantation, rats were implanted with a steel guide
cannula (Plastics One) using the following coordinates relative to bregma:
A/P, 2.5 mm; D/V, 8.5 mm. Animals were stereotaxically implanted with
a bilateral steel guide cannula (Plastics One) positioned 2 mm above the
caudomedial nucleus of the solitary tract (cannula holding bar in a 10 rostro-
caudal angle, coordinates relative to occipital suture: A/P, +1.5 mm; D/V,
6.8 mm; ± 0.75 lateral to midline). Beveled stainless steel injectors (30 gauge
for the fourth ventricle and 33 gauge mounted onto a 26 gauge sleeve for the
NTS) extending 2.0 mm from the tip of the guide cannulas were used for
injections. Animals were allowed a 1 week recovery. Accurate cannula place-
ment was confirmed by consumption of more than 1.5 g of chow within the
60 min after a parenchymal injection of 24 mg 5-thio-D-glucose (Sigma) in
100 nl artificial cerebrospinal fluid (aCSF; Harvard Apparatus) per side (Ritter
et al., 2000).
Feeding Behavior
Before all experiments, animals were adapted for 1 week to individual feeding
chambers (Med Associates) with ad libitum access to a standard chow diet
(Bioserv 45 mg precision pellets, F0165). Meal patterns were determined as
previously described (Azzara et al., 2002).
NTS Injection Studies
Injections were performed in a crossover manner according the injection
designs described below, and at least 4 days elapsed between each injection.
Injection Design 1
Rats fasted overnight received a 2 min NTS injection (100 nl per side at
50 nl/min) of aCSF alone or together with 2.1 mM L-leucine (i.e., 210 pmol
per side; Sigma) or 2.1 mM L-valine (Sigma) 1 hr before the onset of the
dark. Access to food was restored immediately after the injection, food intake
was continuously recorded for the following 24 hr, and body weight was
measured before and 24 hr after the injection. Using fluorescently labeled
leucine (Phoenix Pharmaceuticals, custom made), we confirmed that in these
conditions injections targeted the cmNTS, spreading throughout the rostro-
caudal extent of the area postrema, from approximately 13.5 to 14.0 mm
posterior to bregma (Paxinos and Watson, 2001) (Figure S2).
Injection Design 2
Rats fasted overnight received a 6min i.c.v. injection of 2 ml aCSF alone or with
0.1 nmol SHU9119 (Bachem) followed 2 hr later by a 2 min NTS injection of
aCSF alone or together with 2.1 mM L-leucine 1 hr before the onset of the
dark. Access to food was restored immediately after the second injection,
and food intake was continuously recorded for the following 24 hr.
Injection Design 3
Rats fasted overnight received (1) a 2 min bilateral NTS injection of 100 nl
DMSO (Sigma) alone or with 1.25 mg rapamycin (EMD Chemicals) per side,
(2) an i.p. injection of 100 mg/kg BW saline alone or with 0.5 mg/kg BW nonsul-
fated CCK octapeptide (Bachem), (3) a 2 min bilateral NTS injection of 100 nl
aCSF alone or with 3 ng rat recombinant leptin (R&D Systems) per side, (4)
a 2 min bilateral NTS injection of 100 nl aCSF alone or with 2 pmol melanotanCell M2 (Bachem) per side, or (5) a 2min bilateral NTS injection of 100 nl DMSO:saline
(50:50) alone or with 25 ng U0126 (Bachem) per side, followed by a bilateral
injection of 100 nl aCSF alone or together with 2.1 mM L-leucine 1 hr before
the onset of the dark. Access to food was restored immediately after the injec-
tions, food intake was continuously recorded for the following 24 hr, and body
weight was measured before and 24 hr after the injection.
Injection Design 4
Rats were trained to rapidly eat a chowmeal after an overnight fast. On the day
of the test, overnight-fasted rats were refed for 1 hr and then received a 2 min
NTS injection (100 nl per side at 50 nl/min) of DMSO alone or together with
2.5 mg rapamycin. Access to food was restored immediately after the injection,
food intakewas continuously recorded for the following 24 hr, and body weight
was measured before and 24 hr after the injection.
Viral Preparation and Brain Injection
Adenovectors expressing LACZ or a constitutively active mutant of p70 S6
kinase 1 were prepared as previously described (Blouet et al., 2008). In brief,
rat p70 S6 kinase 1 (shorter form of Rps6kb1) complementary DNA was
subcloned using RT-PCR from rat liver. Mutations in S6K at F5A, T389E,
and RSPRR to ASPAA (AA410–AA414) were respectively introduced using
PCR-based mutagenesis, with confirmation of whole sequences. Adenovirus
for S6K mutants were generated with the Adeno-X expression system version
1 (BD Clontech), with a substitution of the promoter in the shuttle vector from
CMV to CAG (Ono et al., 2003). LACZ adenovirus was prepared as previously
described (Ono et al., 2003). Adenovirus were amplified in 293 cells and
purified with an Adenopure kit (Puresyn). Adenoviral titers were measured
by endpoint dilution assay with 1:3 serial dilutions on a 96-well plate of
HEK293 cells.
Adenoviral Injections and Metabolic Phenotyping
Using stereotaxic surgery performed under ketamine/xylazine anesthesia, rats
were bilaterally injected with adenovirus (23 108 pfu in 200 nl/side over a 4min
period) expressing a constitutively active mutant of S6K (CA S6K) or LACZ in
the NTS. Body weight and feeding behavior were monitored from 4 days
before to 7–10 days after virus administration. Body composition was deter-
mined by magnetic resonance spectroscopy with an ECHO MRS instrument
(Echo Medical Systems). Leptin sensitivity was measured in 24 hr-fasted
rats that received an i.p. injection of saline alone or with 0.5 mg/kg BW rat
recombinant leptin. Twenty-four hour food intake and body weight gain after
the i.p. leptin injection were adjusted to 24 hr food intake and body weight
gain after the i.p. saline injection, and the deltas were used as indices or leptin
sensitivity. Successful adenovirus administration in the NTS was confirmed by
immunoblot analysis with S6K antibody, as described below.
Biochemical Analyses
Plasma insulin and leptin levels were measured with ELISA assays (ALPCO).
Tissue Collection for Immunostaining
Brains were perfused transcardially via a 23 gauge needle placed in the left
ventricle with 200 ml of 0.1 M heparinized PBS (pH 7.4) followed by 200 ml
of 4% paraformaldehyde in PBS, and the fixed brains were cryoprotected in
30% sucrose. Coronal hypothalamic sections of 30 mm thickness were
prepared on a freezing microtome.
Immunostaining
Free-floating sections were incubated for 15 min in 1% hydrogen peroxide,
washed two times in PBS, and blocked 2 hr in 0.3% Triton X-100 and 5%
NGS in PBS before being incubated overnight at 4C in phospho-S6 ribosomal
protein (Ser235/236) rabbit antibody (1:50, Cell Signaling Technology), mouse
anti-dopamine b hydroxylase (1:1000, Millipore), mouse anti-tyrosine hydrox-
ylase (1:100, Immunostar), or rabbit anti-proopiomelanocortin precursor
(1:200, Phoenix Pharmaceuticals) in 0.3% Triton X-100 and 5%NGS. Sections
were then washed and incubated for 2 hr with Alexa Fluor 594 goat anti-mouse
IgG or Alexa Fluor 488 goat anti-rabbit IgG, floated onto superfrost Plus micro-
scope slides (Fisher), and coverslippedwith Vectashield (Vector). Specificity of
the antibody against proopiomelanocortin precursor was confirmed with
POMC-GFP mice [C57BL/6J-Tg(Pomc-EGFP)1Low/J from the Jackson
Laboratories] (Figure S3). In brief, free-floating sections were incubated inetabolism 16, 579–587, November 7, 2012 ª2012 Elsevier Inc. 585
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precursor (1:200, Phoenix Pharmaceuticals), and secondary detection was
performed with Alexa Fluor 488 donkey anti-goat and Alexa Fluor 594 donkey
anti-rabbit.
Image Analysis
Images of tissue sections were digitized, and areas of interest were outlined on
the basis of cellular morphology. pS6-, TH-, DBH-, and POMC-positive nuclei
within the nucleus of cmNTS at the midlevel of the area postrema (7.3–7.4 mm
caudal to bregma) were quantified with automated image analysis software
(Image J) and were based on four animals/group.
Micropunch Dissection
Brainstem sections spanning the rostrocaudal extent of the area postrema,
from approximately 13.5 to 14.0 mm posterior to bregma (Paxinos and
Watson, 2001), were prepared from freshly extracted rat brain. The cerebellum
was quickly removed with fine forceps. Sections were placed on a stainless
steel plate cooled by liquid nitrogen and immersed in liquid nitrogen for 2 s.
The spinal trigeminal nuclei forming the lateral borders of the section were
excised and discarded. The remaining brainstem slice was then excised hor-
izontally at the ventral aspect of the central canal, dissecting the dorsal vagal
complex (DVC) from the more ventral hypoglossal nucleus and basal brain-
stem. The remaining DVC, including the area postrema, the NTS, and the
dorsal motor vagal nucleus, was collected. All micropunches were snap frozen
in liquid nitrogen.
Western Blot Analysis
Western blot analyses were performed as previously described (Blouet et al.,
2008). In brief, brain micropunches were homogenized in 50 mM Tris, 1 mM
EGTA, 1 mM EDTA, 50 mM sodium fluoride, 10 mM glycerophosphate,
20 mM sodium pyrophosphate, 2 mM orthovanadate, 2 mM PMSF, 1% Triton,
and complete phosphatase inhibitor cocktail (Roche). Protein extracts
were run on Criterion gels (Bio-Rad) and blotted onto nitrocellulose mem-
branes. Immunoblots were incubated in phospho-p44/42 MAPK (Thr202/
Tyr204), p44/42 MAPK, phospho-p70 S6 kinase (Thr389), phospho-S6
ribosomal protein (Ser235/236), p70 S6 kinase (Millipore), or b-actin (Santa
Cruz Biotechnology) IgG, followed by incubation in fluorescent (Rockland
Immunochemicals) or HRP-linked secondary antibodies. Proteins were
detected with either the fluorescence-based Odyssey Infrared Imaging
System (LI-COR Biosciences) or enhanced chemiluminescence (ECL Plus,
GE Healthcare). We confirmed that the bands used to quantify the activation
status of the mTOR/S6K1 pathway from phospho-p70 S6 kinase (Thr389),
phospho-S6 ribosomal protein (Ser235/236) blots were rapamycin sensitive
(Figure S4).
Statistical Analysis
All data, presented as means ± SEM, were analyzed with GraphPad Prism 5.
For all statistical tests, an a risk of 5% was used. All kinetics were analyzed
with a mixed model for repeated measurements. Multiple comparisons were
tested with an ANOVA and adjusted with Tukey tests.
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